DONATE

Free Support Line: 833-275-4222

Walk to End Bladder Cancer

Clinical Trials

A clinical trial is a research study that tries to find better ways to prevent, screen for, diagnose, or treat a disease like bladder cancer. 

Bladder cancer patients should talk with their healthcare team to determine whether a clinical trial is an option for their specific situation. They should carefully weigh the potential benefits and risks, ensuring they make an informed decision about their treatment plan.

Search for a clinical trial

You can search for a clinical trial below by bladder cancer disease state, state of residence and you can also look for trials nearest to you.

About Clinical Trials

✕To help find trials near you, you need to allow BCAN to access your location
Ok

Featured Trials
Title State Sponsoring Organization
Urine Methylation Markers in UTUC North Carolina Duke University
MT-4561 in Patients With Various Advanced Solid Tumors Multi-State Mitsubishi Tanabe Pharma America Inc.
SLV-154 Treatment of Metastatic Solid Tumors Missouri Solve Therapeutics
T3011 in Patients With BCG-Unresponsive High Risk NMIBC California ImmVira Pharma Co. Ltd
Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents Florida H. Lee Moffitt Cancer Center and Research Institute
In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial Florida Mayo Clinic
Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC) New York Memorial Sloan Kettering Cancer Center
Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer California University of California, San Francisco
sEphB4-HSA in EphrinB2-High Solid Tumors California Vasgene Therapeutics, Inc
Title State Sponsoring Organization
Urine Methylation Markers in UTUC North Carolina Duke University
MT-4561 in Patients With Various Advanced Solid Tumors Multi-State Mitsubishi Tanabe Pharma America Inc.
SLV-154 Treatment of Metastatic Solid Tumors Missouri Solve Therapeutics
T3011 in Patients With BCG-Unresponsive High Risk NMIBC California ImmVira Pharma Co. Ltd
Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents Florida H. Lee Moffitt Cancer Center and Research Institute
In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial Florida Mayo Clinic
Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC) New York Memorial Sloan Kettering Cancer Center
Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer California University of California, San Francisco
sEphB4-HSA in EphrinB2-High Solid Tumors California Vasgene Therapeutics, Inc

Learn more about the different phases clinical trials here.

This clinical trial dashboard would not be possible without the generous support of our corporate partners including, AstraZeneca, Bicycle Therapeutics, CG Oncology, Daiichi Sankyo, Ferring Pharmaceuticals, Fidia Farmaceutici, Flare Therapeutics, ImmunityBio, Johnson and Johnson, Lilly, Protara Therapeutics and Urogen.

Related Stories